The Obsidio Conformable Embolic recall related to an increased risk for bowel ischemia is the most serious kind, the FDA said on Wednesday, citing two deaths associated with the issue. An ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Boston Scientific announced it received FDA 510(k) ...

HOUSTON -- Preoperative embolization of meningioma was associated with improved relapse-free survival (RFS) in a retrospective propensity-matched review. Surgery without embolization was associated ...

Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which ...

Boston Scientific Corporation BSX recently announced the acquisition of Obsidio, Inc. This privately-held company is the renowned developer of the FDA-authorized Gel Embolic Material (GEM) technology.

Boston Scientific Corp.’s intent to acquire Penumbra Inc. for $14.5 billion will not only allow it to expand its minimal invasive care portfolio in areas such as embolization and peripheral vascular ...

One of the key drivers of the detachable embolization coils market is the rapid shift toward minimally invasive endovascular therapies. Interventional neuroradiology and vascular surgery departments ...